Results 61 to 70 of about 2,528,532 (307)

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Clinical characteristics of patients with a family history of psoriasis: an observational epidemiological study in Chinese Han population

open access: yesFrontiers in Medicine
IntroductionPsoriasis, a chronic inflammatory skin disease, is believed to be influenced by both genetic and environmental factors. Despite this understanding, the clinical epidemiological status of psoriasis patients with a family history of the disease
Lu Cao   +9 more
doaj   +1 more source

Prospecting the protein design landscape

open access: yesFEBS Letters, EarlyView.
This review outlines the current state of various protein design approaches. We discuss the current possibilities enabled by recently released tools, highlight future avenues to pursue in protein design, and underscore the crucial role of key databases and resources for successful protein design workflows.
Jakob R. Riccabona   +4 more
wiley   +1 more source

Prospects and challenges of salivary gland tissue engineering in Sjögren’s syndrome

open access: yesExpert Reviews in Molecular Medicine
Sjögren’s syndrome (SS) is characterised by an autoimmune response that targets the salivary and lacrimal glands, resulting in dry mouth and eyes. In addition to these local manifestations, the systemic involvement of other organs can also occur. Current
Xinying Fan   +7 more
doaj   +1 more source

Biosimilars in allergic diseases

open access: yes, 2016
This article realizes an overview on the world of biological and biosimilar drugs in allergic and immunologic diseases' treatment strategies. We started talking about the history of asthma treatment's progresses, continuing to daily biological therapies,
Bagnasco, Diego   +5 more
core   +1 more source

Metastatic niche shaped by host factors influences disseminated cancer cell fate

open access: yesFEBS Letters, EarlyView.
Metastasis is shaped not only by cancer cells but also by the environments they encounter. This review explores how factors such as aging, diet, the microbiome, lifestyle, and environmental exposures remodel organ‐specific niches in the lung, liver, bone, and brain, influencing where metastatic cells survive, remain dormant, or grow, and ultimately ...
Gwennan Delyth Ward   +2 more
wiley   +1 more source

The relation of periodontal diseases to systemic diseases [PDF]

open access: yes, 2008
Background: The relationship between systemic disorders and periodontal disease has been studied extensively. With few exceptions, it is more accurate to consider systemic diseases to be contributing factors in the pathogenesis of periodontal disease ...
Djamil, Melanie Sadono   +1 more
core  

Immunologic characteristics.

open access: yes, 2019
Immunologic characteristics.
Eun Sang Yoo (7423334)   +10 more
core   +1 more source

Exposure to SARS-CoV-2 and Infantile Diseases

open access: yes, 2023
Background and Aim Immune response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in newborns and children after prophylactic immunization is currently a relevant research topic. The present study analyzes the issue by examining the
Darja Kanduc
core   +1 more source

Smaller is better: nanobodies meet NMR

open access: yesFEBS Letters, EarlyView.
Nanobodies are single‐domain antigen‐binding fragments derived from camelid heavy chain antibodies. Their small size, high stability, and exceptional specificity make nanobodies uniquely useful probes for NMR studies of protein dynamics, transient conformational states, and protein–protein interactions.
Oleg Y. Dmitriev
wiley   +1 more source

Home - About - Disclaimer - Privacy